In the context of human disease, the mechanisms whereby transcription factors reprogram gene expression in response to injury are not well understood. This is particularly true in kidney podocytes, injury to which is the common and initial event in many processes that lead End Stage Kidney Disease. WT1 is a master regulator of gene expression in podocytes, binding nearly all genes known to be crucial for maintenance of the glomerular filtration barrier. Here, using purified populations of podocytes and glomeruli, we investigated WT1-mediated transcriptional reprogramming during the course of podocyte injury. Using the Adriamycin murine model of Focal Segmental Glomerulosclerosis, we discovered that podocyte injury led to increased intensity of WT1 binding and to the acquisition of new WT1 binding sites, both at previously identified target genes and at newly bound target genes, providing mechanistic insight on the transcriptional response to injury. We also observed a previously unrecognized transient increase in expression of WT1 target genes in both mice and human kidney organoids.
INTRODUCTION
Focal Segmental Glomerulosclerosis (FSGS) is among the most debilitating and least treatable forms of chronic kidney disease and often leads to End Stage Kidney Disease, requiring dialysis and/or transplantation. Podocytes are highly differentiated cells that maintain the glomerular filtration barrier (GFB) through the extension of foot proceses that interdigitate with foot processes of adjacent podocytes, thereby assembling a scaffold that supports a network of capillaries within each glomerulus. In most types of FSGS, podocyte injury is the incipient event 1 , characterized by foot process effacement and podocyte detachment, resulting in loss of the GFB and severe proteinuria 2 . Several proteins are implicated in maintaining podocyte structural organization, including Synaptopodin, Nephrin and Podocin. One common characteristic of glomerular injury is the decreased abundance of key proteins that maintain the GFB, suggesting that transcriptional regulation of genes encoding these proteins has an important role in the pathogenesis of glomerular disease.
Our previous study and others identified WT1 as one of the most upstream transcription factors (TF) regulating gene expression in podocytes 3, 4 and one of the earliest known markers of podocytes during kidney development 5 . Decreased expression of WT1 and mutations in WT1 gene have been described in several forms of glomerular disease [6] [7] [8] [9] [10] . Most human nephrotic syndrome genes have been identified as WT1 targets, including NPHS1, NPHS2, and INF2 4 . However, the mechanism whereby WT1 regulates gene expression during the initiation and progression of glomerular disease remains unknown.
In the present study, we focused on deciphering the transcriptional mechanisms through which WT1 regulates podocyte gene expression during injury. Genomewide analysis of both WT1 DNA occupancy and podocyte gene expression during the course of Adriamycin-mediated injury revealed a transient increase in the number and binding intensity (defined as peak height in ChIP-seq data sets) of WT1-bound sites as well as an increase in the expression of crucial podocyte genes at early stages of injury, that may reflect an attempt to repair podocytes. We demonstrated that WT1 is required to maintain active chromatin marks at podocyte genes, and that podocyte injury leads to the conversion from active to repressive histone modifications at Nphs2 and Synpo. Taken together, this study provides strong evidence that, during injury, podocyte gene expression is subject to transcriptional reprogramming under the direct control of WT1, indicating that podocytes possess an intrinsic repair program, acting at the level of gene expression. overlaps the second exon ( Fig. 1f ). H3K4me3 and H4K8ac were greatly reduced after inactivation of WT1 at these sites ( Fig. 1g ) and the repressive histones marks H3K9me3 and H3K27me3 were increased ( Fig. 1g ), confirming that histones modification complexes that maintain the active chromatin state also inhibit the placement of repressive marks on histones 13 . Similar results were observed in vitro with immortalized podocytes ( Supplementary Fig. 1a , b), demonstrating that WT1 has a crucial role in maintaining the open chromatin state at its target genes in podocyte.
Transient increase of podocyte gene expression in ADR-injured mice and human kidney organoids
To analyze WT1-mediated transcriptional reprogramming during the course of injury, we used the Adriamycin (ADR) model for podocyte injury, a well-recognized murine model for FSGS 14, 15 . Two different strains of mice were used in this study:
mTmG-Nphs2cre mice that are less sensitive to ADR, from which podocytes are isolated by FACS, and BALB/cJ, a prototypical highly ADR-sensitive strain 16 . To determine the time course of ADR-induced podocyte injury, we first analyzed the level of proteinuria of mTmG-Nphs2cre and BALB/cJ mice treated with either ADR or phosphate buffered saline (PBS) as a control vehicle. mTmG-Nphs2cre mice required a higher dose and a second injection to develop maximal proteinuria after two weeks ( Fig. 2a ), whereas ADR induced proteinuria in BALB/cJ mice over a one-week period ( Supplementary Fig. 2a ). been shown to decrease after the onset of glomerular disease 17, 18 . However, in BALB/cJ isolated glomeruli, we observed a several-fold increase in Wt1 expression after ADR treatment, before Wt1 fell to low levels ( Supplementary Fig. 2b ).
Concomitant with the transient increase in Wt1, Nphs2 and Synpo also dramatically increased before falling to nearly undetectable levels ( Supplementary   Fig. 2b ). Although, in mTmG-Nphs2cre FACS-isolated podocytes, Wt1 and Nphs2 levels did not increase to the extent observed in BALB/cJ after ADR, Synpo did
show an over two-fold increase, suggesting that while less dramatic, there also appeared to have been transcriptional reprogramming in these mice ( Fig. 2b ). In mTmG-Nphs2cre mice, WT1 protein levels fell at day 9 after ADR (D9). Podocin showed a slight increase whereas Synaptopodin showed an over three-fold increase at Day 5 after Adriamycin (D5), then falling dramatically ( Fig. 2c ). By immunofluorescent detection, WT1 was also present in podocyte nuclei until D5 in mTmG-Nphs2cre and D3 in BALB/cJ, after which it was decreased ( Fig. 1d and Supplementary Fig. 2c ).
We next investigated the effect of ADR on organoids derived from human embryonic stem cells. In addition to WT1, NPHS2 and SYNPO, we also examined NPHS1, encoding the slit diaphragm protein Nephrin, because of its importance in genetic kidney disease. We observed similar transient increases in WT1 and target genes (Figure 2e ,f,g). Even though transcript levels continued to be expressed through D4 ( Fig. 2e ), protein levels for WT1, Synaptopodin, Nephrin (immunofluorescence only) and Podocin were greatly decreased starting from D4 by either western blot or immunofluorescent detection ( Fig. 2f,g) . Podocalyxin, a glycocalyx sialoprotein located at the apical and lateral surface of podocytes could be detected, albeit at lower levels, through D10, confirming their presence of podocytes throughout the injury process ( Fig. 2g ). Therefore, human podocytes also respond to injury by transiently increasing expression of WT1 and target genes, thus validating human kidney organoids as a model to study glomerular injury. Since protein levels did not precisely overlap with maximal RNA levels, there may also be translational regulation affecting their expression during injury. Nevertheless, the decrease in WT1 and target gene expression demonstrated significant transcriptional reprogramming during the course of the injury.
Dynamics of WT1 occupancy during ADR-induced injury
The overall level of WT1 in podocytes may not be representative of its binding at specific enhancers or TSSs. The pattern of WT1 binding was indeed distinct at each site (shown in figure 3d) for Nphs2 and Synpo genes during injury ( Fig. 3a ).
In mTmG-Nphs2cre mice, the most significant changes were increased binding at
Nphs2-1 at D10 and decreased binding at Nphs2-3 after D5. Binding at all three Synpo sites transiently increased, before falling to levels below that observed in uninjured mice, correlating with gene expression. This response is more dramatic in BALB/cJ mice, consistent with their greater sensitivity to ADR ( Supplementary   Fig. 2d ). An important point emerges from this study that may be generalizable to transcription factor biology in general and particularly in response to disease. WT1 Tcf21 Lower panels: TF motifs identified within the numbered conserved elements. binding at distinct enhancers and promoters does not simply reflect the overall level of WT1, but may differ between individual binding sites. Recent studies have demonstrated redundancy among multiple enhancers affecting expression of individual genes during development 19 . In contrast, our results suggest that enhancers may make distinct contributions to gene expression during the response to injury.
Chromatin remodeling during ADR-induced injury

As WT1 occupancy maintains open chromatin and ADR results in loss of WT1
binding at target genes ( Fig. 1f ), we interrogated histone modifications at WT1 binding sites after ADR treatment ( Fig. 3b ). All WT1 binding sites were converted to closed chromatin state at D14 after ADR injury ( Fig. 3b ). H3K4me1, that marks active enhancers and promoters, was increased at WT1 binding sites at D9 ( Fig.   3c ), correlating with increased binding of WT1. H3K27ac, that marks active enhancers, was also increased at D9, except at the Nphs2-3 site present within a TSS ( Fig. 3c ). Similar results were observed in vitro ( Supplementary Fig. 1c,d ).
Thus, ADR injury results in a conversion from an open to closed chromatin state at WT1 target genes.
Genome wide dynamics of WT1 binding during injury
To identify general mechanisms through which WT1 regulates gene expression during the course of ADR-induced podocyte injury, we performed WT1 ChIP-seq using isolated glomeruli from mTmG-Nphs2cre and BALB/cJ mice and RNA-seq using FACS-isolated podocytes from mTmG-Nphs2cre mice obtained at the onset of proteinuria (D9) and at a point of maximal proteinuria (D14), (Fig.1a ). In mTmG-Nphs2cre mice, the global number of WT1 bound sites increased from 23,163 in control mice to 31,639 at D9 before falling dramatically to 6,567 binding sites at D14 ( Fig. 4a ). 11,266 binding sites were uniquely present at D9 (Fig. 4a ). Many of these sites were present at genes already bound in uninjured podocytes (n=2,839; Fig. 4a and examples in Supplementary Fig. 3a ). However, some of these sites were found at 1,245 genes not bound in control or D14 ( Fig. 4b and examples in Supplementary Fig. 3b ). Thus at D9, WT1 both bound additional sites at previously identfiied target genes, and acquired new target genes ( Fig. 4b ). Similar to D14 mTmG-Nphs2cre mice, proteinuric BALB/cJ mice also lost many WT1 binding sites at D7 after ADR ( Supplementary Fig. 4a ).
Genome-wide, promoter regions were over-represented among WT1 binding sites (Supplementary figure 3a) . The global distribution of WT1 binding sites did not change during injury in either strain of mice ( Supplementary Fig. 4b and 5a ).
However, the intensity of WT1 binding changed over the course of injury. In mTmG-Nphs2cre mice, 93% of differentially bound sites increased at D9 whereas almost all binding sites significantly decreased at D14 ( Supplementary Fig. 5b ). In BALB/cJ mice, WT1 binding significantly changed (FDR<0.05) for 52% of the sites during injury, 85% of the differential WT1 binding sites decreased in intensity ( Supplementary Fig. 4c ). We observed differences in the functional distribution among these sites. Most notably, WT1 bound sites that increased in intensity after injury were primarily found in introns (50%) in mTmG-Nphs2cre mice, suggesting that WT1 bound additional intronic enhancer sites during the injury response ( Supplementary Fig. 5b ). These results demonstrate a process whereby, in the early stages of injury, WT1 acquires new binding sites and increases the intensity of its binding at previously bound sites.
Dynamics of WT1 target gene classes during the injury response
We previously defined two classes of WT1 target genes, based on WT1 binding patterns (8): class 1 genes having a single WT1 binding site at the transcriptional start site (TSS +/-1kbp) and class 2 genes having multiple binding sites within a 500 kb region of the TSS including at the TSS. To these, we add class 3 genes having multiple WT1 binding sites but not at the TSS, and class 4 genes that have a single binding site not within 1kb of a TSS (Fig. 4c ). Unbound genes are defined as not having a WT1 binding site within 500 kb of the TSS. Comparable to our previous findings, class 1/2 genes had a higher range of expression levels in uninjured podocytes. Classes 3/4, while expressed at lower levels than class 1/2 genes, were significantly more highly expressed than unbound genes (Fig. 4d) , Thus, WT1
binding is a major determinant of gene expression in podocytes, and binding at the TSS is particularly important.
A large number of genes changed their class designation during the course of injury.
Many genes not bound in uninjured podocytes became transiently bound at D9. A small number of genes changed from class 3/4 to class 1/2 at D9, and returned to class 3/4 or unbound at D14 (Fig. 4e ). Class 2 and 3 genes showed the greatest changes in WT1 binding, the majority increasing at D9 and decreasing at D14 (P<0.001; Fig. 4f , and Supplementary Fig. 4e ). Furthermore, in both strains of mice, many class 1/2 genes became unbound at D14 ( Fig. 4e, Supplementary Fig. 4d ).
At D14, the number of genes with decreased or loss of WT1 binding (defined as either decreased number of binding sites, or binding intensity), greatly outnumbered bound genes (Fig. 4e,f) . These analyses emphasize the importance of WT1 binding for the response to injury in podocytes.
WT1 regulated transcriptional network
Eukaryote TFs generally act combinatorially to determine tissue-specific patterns of gene expression. Therefore, we examined TF motif enrichment near those WT1 binding sites whose intensity significantly increased at D9. This analysis highlighted motifs predicting FOX, LMX1B, TCF21 and MAFB as TFs potentially co-binding with WT1 ( Fig. 4g ), all well known to be important in podocytes [20] [21] [22] [23] , suggesting that the response to injury involves the basic transcriptional machinery already present in podocytes. TEAD sites were also predicted, as were FOS/JUN sites, the former predicting a role for YAP/TAZ in regulating the injury response and the later suggesting a role for the AP-1 TF, described to confer protection from glomerulonephritis 24 . Near WT1 sites uniquely bound at D9, motifs predicting FOX TF co-binding were present, but not other podocyte TFs (Fig. 4h ), suggesting that during the injury response, WT1 and FOX TFs may additionally activate a set of enhancers. Interestingly, motif analysis at sites where WT1 binding was decreased at D14 predicted an entirely different set of TFs, including SP2, NRF1 and E2F1/4 ( Fig. 4i ). NRF1 and E2F1/4 have been described as repressive TFs [25] [26] [27] , suggesting that by D14, a portion of WT1's overall activity may be as part of a repressive complex involved in decreasing the expression of many target genes.
Predicted TF motifs at the Nphs2 and Synpo genes are shown in Fig. 3d , (adapted from 4 ). Interestingly, this analysis also indicates that individual enhancers may be bound by distinct groupings of TFs, suggesting that levels of gene expression reflect the integration of multiple enhancers, each of which might contribute differently to gene expression.
Functional implications of WT1 dynamic binding
To understand the functional implications of WT1 dynamic binding, we performed RNA-seq analysis on control, D9 and D14 FACS-isolated podocytes from mTmG-Nphs2-Cre mice. GO analysis based on RNA-seq ( Fig. 5a ) and ChIP-seq ( Supplementary Fig. 6a ) data sets were largely consistent with each other in neuron projection extension involved in neuron projection guidance (11) nuclear import (34) protein targeting to nucleus (34) single−organism nuclear import (34) protein import into nucleus (34) protein localization to nucleus (41) positive regulation of cell morphogenesis involved in differentiation (27) regulation of cytoskeleton organization (49) actin filament organization (42) cell−cell adhesion via plasma−membrane adhesion molecules (34) homophilic cell adhesion via plasma membrane adhesion molecules (28) regulation of cell morphogenesis involved in differentiation (47) nucleoside monophosphate metabolic process (42) ribose phosphate metabolic process (63) purine nucleoside monophosphate metabolic process (41) purine ribonucleoside monophosphate metabolic process (41) ribonucleoside triphosphate metabolic process (42) purine ribonucleoside metabolic process (48) ATP metabolic process (40) purine ribonucleoside triphosphate metabolic process (42) purine nucleoside triphosphate metabolic process (43) purine nucleoside metabolic process (49) ribonucleoside metabolic process (51) small molecule catabolic process (48) nucleoside triphosphate metabolic process (47) nucleoside metabolic process (55) glycosyl compound metabolic process (59) response to oxidative stress (14) intrinsic apoptotic signaling pathway (12) signal transduction by p53 class mediator (13) regulation of actin cytoskeleton organization (55) cell−substrate adhesion (54) regulation of actin filament−based process (61) positive regulation of cell−cell adhesion (22) leukocyte aggregation (34) lymphocyte aggregation (34) vascular process in circulatory system (21) regulation of body fluid levels (29) tissue migration (24) renal system development (59) epithelium migration (24) peptidyl−tyrosine modification (26) epithelial cell migration (24) peptidyl−tyrosine phosphorylation (26) ameboidal−type cell migration (64) positive regulation of cell adhesion (32) endothelial cell migration (21) angiogenesis (42) 0.03 0.01 (Supplementary Fig. 6a ). Interestingly, gene expression of, and binding of WT1 to, cytoskeletal and adhesion genes sets was decreased at D14, suggesting that by this point, repair processes in podocytes are greatly diminished ( Fig. 5a and Supplementary Fig. 6b ). GO analysis of the 1,245 genes uniquely bound at D9 (Fig. 4j ) were similar to those identified as having increased intensity of WT1 binding at D9 ( Supplementary Fig. 6b ), indicating that the early response to injury largely involved amplification of the same pathways already operational in uninjured podocytes. Genes represented by GO terms related to RNA stability, nucleotide metabolism and splicing process showed decreased WT1 binding at D14
( Supplementary Fig. 6b ), though their expression levels increased (Fig. 5a ), further suggesting a potential repressive function for WT1 (examples of genes in Supplementary Fig. 6c,d) . In BALB/cJ mice, GO analysis of genes at which binding increased after injury included regulation of protein processes, while genes at which WT1 binding decreased after injury included paraxial mesodermal development, a set that includes Foxc2 and Tead1 ( Supplementary Fig. 4f,g) .
WT1 target gene expression changes during injury
WT1 bound genes were found both among those that showed increased and decreased expression levels, further demonstrating that WT1 is an important determinant of gene expression in podocytes. This was the case at both D9 and D14 (Fig. 5b ). Class 2 and 3 genes also showed the greatest overall differences in expression levels between control and D9 or D14 (Fig. 5b) . Thus, having multiple WT1 binding sites confers a greater likelihood of gene expression levels changing during the injury process.
Of the 1,245 genes uniquely bound by WT1 at D9 (Fig. 4b) , 223 increased their expression by at least 2-fold ( Fig. 5c and Supplementary Fig. 5c ) and 68 became expressed at D9. Thus, the majority of genes uniquely bound at D9 did not show significant differential expression between control and D9 or D14, demonstrating that changes in expression are more complex than simply reflecting de novo or changes in WT1 binding. Examining the entire set of WT1-bound genes, there was a slight increase in transcript levels, indicating that many WT1-bound genes are not over-expressed during the response to injury (Fig. 5d ). Overall, 38% and 64% of differentially expressed genes showed a change in WT1 binding intensity at D9 and D14 respectively ( Supplementary Fig. 5d ). However, 50% of WT1-bound genes whose expression significantly changed at D9, also showed a change in the pattern of WT1 binding. At D14, over 90% of WT1-bound genes whose expression changed showed a change in WT1 binding intensity (Fig. 5e ), emphasizing the importance of WT1 binding for gene expression during injury.
Podocyte-specific gene expression is transiently increased during ADRinduced injury
Transcriptomic data was used to analyze WT1 binding and the expression profile of a recently described podocyte-identifying gene set 11 during injury. Most members of this set were class 2 genes. While some class 2 genes remained in the same class, several others converted to class 3 or were unbound by D14 (Fig. 5f ). Expression of this gene set significantly increased at D9 (P<0.01) and significantly decreased at D14 (P<0.001; Fig. 5g ), as did the average intensity and the number of WT1 peaks ( Fig. 5h) . Interestingly, while the majority of genes acquired additional WT1 bound sites at D9, several of these genes actually decreased their expression level ( Fig.   5i ), again indicating that increased number of WT1 bound sites by itself does not necessarily confer increased expression. However, by D14, we observed a stronger correlation between the changes in number of WT1 peaks and expression levels ( Fig. 5j ). Similar observations were made for the correlation between WT1 binding intensity and expression (Left panels: Fig. 5i,j) . In contrast, within a defined set of tubule-expressed genes 11 , WT1 only bound a subset of genes. Expression of these genes generally appeared to be regulated independently of WT1 binding ( Supplementary Fig. 7b ), with increased expression at D14, suggesting that podocytes may be losing their identity late in the injury process.
WT1 binds at genes encoding other major TFs found in podocytes, including FOXC2, LMX1B, TCF21 and MAFB 4 ; the intensity of WT1 binding at most sites greatly decreases by D14 ( Supplementary Fig. 8a,b) . Based on RNA-seq analysis,
DISCUSSION
Previous studies have identified WT1 target genes sets in podocytes and nephron progenitor cells 3, 4, 28 . In podocytes, WT1 targets most familial nephrotic syndrome and FSGS genes 4 . ( Supplementary Table S4 ). Additionally, among nearly 900 recently identified eQTLs for human nephrotic syndrome 29 assembly requires the conserved action of many actin binding and regulatory proteins, many of which are WT1 target genes. For a large number of these genes, WT1 binding and their expression levels were increased at D9. It is not known whether foot process morphology results from a particular combination of cytoskeletal and adhesion proteins found in podocytes, such as specific combinations of Rho GAPs and GEFs. If this is indeed found to be the case, then WT1, acting with other TFs, may provide the specificity in determining the set of cytoskeletal regulatory proteins expressed in normal podocytes and amplified in response to injury. Integrin receptors for the extracellular matrix are also integrally involved in determining cell morphology. a3b1 integrin is known to be essential for foot process formation 31 and indeed Itga3 and Itgb1 are class 2 genes and among the most highly expressed integrins in podocytes ( Supplementary Fig. 9 ). aV and b5 integrins, that form a heterodimer implicated in podocyte injury 32, 33 , are also bound by WT1 and the expression of Igtav increases in response to injury ( Supplementary Fig. 9 ).
In contrast to cytoskeleton and adhesion-related genes, many genes involved in energy metabolism were found to have decreased expression levels particularly at D14. Mitochondrial damage has been shown to be a major contributor to Adriamycin induced podocyte damage 34, 35 . WT1 also binds several genes encoding components that regulate the tricarboxylic acid cycle and ATP production in mitochondria. In many cases WT1 binding was inversely correlated with gene expression, suggesting that in addition to serving as a transcriptional activator, WT1 may for distinct gene sets act in a repressor complex. Such a function has previously been demonstrated for WT1 36, 37 , however it is not known what determines an activator versus repressor function for WT1.
Based on our results, we suggest a model whereby WT1, along with cofactors, activates a set of TFs that may form a complex to regulate the transcription of specific podocyte genes. In injured podocytes, an early response occurs defined by an increase in WT1 DNA binding that may recruit additional enhancer elements that loop into the TSS, increase activating epigenetic marks in the vicinity of the TSS and recruit additional coactivators to increase transcription at target genes (summarized in Fig. 6 ). This leads to an open chromatin conformation resulting in an increase of gene expression crucial to maintain podocytes function. This attempt at repair is followed by decreased expression of WT1, that in turn results (WT1 CKO) were obtained by breeding WT1 flox/+ mice 39 with Nphs2-CreERT2 a tamoxifen-inducible improved Cre recombinase (CreERT2) under the regulation of Nphs2 (podocin) gene promoter 12 and with R26R-tdTomato mice (Jackson Labs 007909). This system was used to isolate tdTomato-expressing podocytes.
WT1 flox/flox /Nphs2-CreERT2/TdTomato mice were given tamoxifen (120mg/kg) during 3 consecutive days by intraperitoneal injections. Kidneys were harvested two weeks after the first injection.
Genotyping primers are given in supplementary material Table S1 .
Glomerular preparation and podocytes isolation
Gomerular preparation and isolation of GFP positive podocytes from 6-8 week old mT/mG-Nphs2cre and WT1 flox/flox /icre/Tdtomato mice was done as described 
Bioinformatic analysis
Alignments. Reads after removing adaptor sequences were mapped to mm9 using Bowtie1 42 with a unique mapping option for ChIP-seq samples. Bowtie1 42 and Tophat2 43 were used for RNA-seq data alignment with no novel junction option.
Visualization of ChIP-seq tracks. Library size normalized read density profiles were generated using SPP R package get.smoothed.tag.density function 44 for WT1
ChIP-seq data in BALB/cJ mice. For ChIP-seq data in mTmG-Nphs2cre mice, aligned reads from replicates were merged after checking reproducibility for each condition. Library size normalized read density profiles were generated using deeptools bamCoverage function with RPGC normalization option and the exclusion of chrX for normalization 45 .
Genomic annotations. The genomic annotations for promoters (with 500 bp margins), exons, 5'UTR, 3'UTR and genic regions were obtained from UCSC genome browser for mm9, refseq annotations. For the intergenic regions, the genic regions were subtracted from the whole genome.
Significant peak detection for WT1 ChIP-seq. Only uniquely aligned reads were used for downstream analysis of ChIP-seq samples. After checking reproducibility between replicates, reads in replicates were combined. Significant peaks were detected using MACS2 callpeak function with q-value=0.05 46 .
Differential bindings of WT1. For the union peaks from two conditions, read counts were obtained and statistically compared between two conditions using Diffbind R package 47 , which internally implements Deseq2 binding sites using the MEME suite AME 49 with default parameters. TF motif sequences were collected from Jaspar core 2018 vertebrate database 50 and Jolma et al 51 . Among the significantly enriched TFs, TFs that are silent or lowexpressed in podocytes were filtered out. The same procedure was done for the prediction of enriched TFs at the significantly decreased WT1 binding sites at D14
in Figure 3C . For the prediction of enriched TFs for unique WT1 peaks at D9, DNA sequences were obtained with a 200 bp window from D9 unique WT1 peak summits at D9. Persistent peak sites found in PBS, D9 and D14 were used as control sites.
TF binding prediction near WT1 binding sites for Nphs2 and Synpo. For the WT1 binding sites overlapping with regions of high conservation scores, the locations of key TFs in podocytes such as TEAD1, FOXC2, TCF21, WT1, MAFB and LMX1B
and several TFs enriched for differential WT1 binding sites during the course of ADR injury were predicted using the MEME suite FIMO with p=0.01 52 . The window size of 100 bp was used from the WT1 peak summits to extract DNA sequences.
Motif database from Jaspar core 2018 vertebrate database 50 Figure 4 . For the analysis of expression changes for WT1 target genes in Figure 4E , a 10 kb margin was used to associate potential targets of WT1 bindings.
Gene classes based on WT1 binding. For each condition, gene classes were defined as in Kann et al 4 and further modified. More specifically, Class 1 gene is the gene whose promoter (+/-1 kb from TSSs) is bound by a single WT1 peak within 500 kb regions of the TSS. Class 2 gene was the gene that has multiple WT1 bindings including peaks at the promoter. Class 3 gene was the gene having multiple WT1 bindings except for a promoter. Class 4 gene was the gene having a single peak in a non-promoter region within a 500 kb window.
Expression quantification. To access expression levels, Cufflinks 54 was with default parameters from the aligned reads. The transcriptional annotations of UCSC mm9 were used. The FPKM (fragments per kilobase of transcript per million mapped reads) values for the expression levels for each gene were calculated.
Differentially expressed genes. Three different methods: Cuffdiff 54 , Deseq2 48 and EdgeR 55 , were used to detect significantly expression changed genes between conditions for a stringent gene set in Figure 4B . Q-value of 0.05 was used for Cuffdiff as a threshold, p-values of 0.05 were used for Deseq2 and EdgeR. The genes detected from at least two methods were used for the gene ontology (GO) analysis. For Figure 4D , differentially expressed genes were determined by relaxed criteria, with a p-value of 0.05 from Cuffdiff.
29
GO analysis. For the significantly changed WT1 binding sites, GREAT version 3 53 was used to determine GO terms associated with the WT1 binding sites with default parameters. For the genes with significant expression changes, DAVID 56 was used. The results were visualized using R package clusterProfiler 57 .
